Literature DB >> 27561704

Mechanisms that Increase Stability of Estrogen Receptor Alpha in Breast Cancer.

Angeles C Tecalco-Cruz1, Josué O Ramírez-Jarquín2.   

Abstract

Estrogen receptor alpha (ER) is a transcriptional regulator that controls the expression of genes related to cellular proliferation and differentiation in normal mammary tissue. However, the expression, abundance, and activity of this receptor are increased in 70% of breast cancers. The ER upregulation is facilitated by several molecular mechanisms, including protein stability, which represents an important strategy to maintain an active and functional repertoire of ER. Several proteins interact and protect ER from degradation by the ubiquitin-proteasome system. Through diverse mechanisms, these proteins prevent polyubiquitination and degradation of ER, leading to an increase in ER protein levels; consequently, estrogen signaling and its physiologic effects are enhanced in breast cancer cells. Thus, increased protein stability seems to be one of the main reasons that ER is upregulated in breast cancer. Here, we highlight findings on the proteins and mechanisms that participate directly or indirectly in ER stability and their relevance to breast cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ER; ER degradation; ER protein stability; ER upregulation; Estrogen signaling pathway

Mesh:

Substances:

Year:  2016        PMID: 27561704     DOI: 10.1016/j.clbc.2016.07.015

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  21 in total

1.  forgeNet: a graph deep neural network model using tree-based ensemble classifiers for feature graph construction.

Authors:  Yunchuan Kong; Tianwei Yu
Journal:  Bioinformatics       Date:  2020-06-01       Impact factor: 6.937

2.  Sirtuin 6 in preosteoclasts suppresses age- and estrogen deficiency-related bone loss by stabilizing estrogen receptor α.

Authors:  Young Jae Moon; Zhongkai Zhang; In Hyuk Bang; Oh Kwang Kwon; Sun-Jung Yoon; Jung Ryul Kim; Sangkyu Lee; Eun Ju Bae; Byung-Hyun Park
Journal:  Cell Death Differ       Date:  2019-02-20       Impact factor: 15.828

3.  Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer.

Authors:  Smruthi Vijayaraghavan; Merih Guray Durak; Nicole M Kettner; Tuyen Bui; Mehrnoosh Kohansal; Min Jin Ha; Bin Liu; Xiayu Rao; Jing Wang; Min Yi; Jason P W Carey; Xian Chen; T Kris Eckols; Akshara S Raghavendra; Nuhad K Ibrahim; Meghan Sri Karuturi; Stephanie S Watowich; Aysegul Sahin; David J Tweardy; Kelly K Hunt; Debu Tripathy; Khandan Keyomarsi
Journal:  Clin Cancer Res       Date:  2019-03-13       Impact factor: 12.531

Review 4.  A review of prognostic and predictive biomarkers in breast cancer.

Authors:  Elaheh Tarighati; Hadi Keivan; Hojjat Mahani
Journal:  Clin Exp Med       Date:  2022-01-15       Impact factor: 3.984

5.  The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer.

Authors:  Kateryna Shostak; Alain Chariot; Seng Chuan Tang; Quentin Lion; Olivier Peulen; Philippe Chariot; Arnaud Lavergne; Alice Mayer; Paula Allepuz Fuster; Pierre Close; Sebastian Klein; Alexandra Florin; Reinhard Büttner; Ivan Nemazanyy
Journal:  Oncogene       Date:  2021-10-29       Impact factor: 9.867

6.  Increased serum concentrations of estrogen-induced growth factors Midkine and FGF2 in NF1 patients with plexiform neurofibroma.

Authors:  Isis Atallah; Ana M Cieza Rivera; Octavio M Rivero Lezcano; Laura Tascón-González; Carolina González-Cortés; Cristina Diez Tascón; Tania Fernández-Villa; Vicente Martín
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

7.  Potential interference of aluminum chlorohydrate with estrogen receptor signaling in breast cancer cells.

Authors:  Vyron A Gorgogietas; Ioannis Tsialtas; Natalie Sotiriou; Vasiliki C Laschou; Aikaterini G Karra; Demetres D Leonidas; George P Chrousos; Evagelia Protopapa; Anna-Maria G Psarra
Journal:  J Mol Biochem       Date:  2018

8.  Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma.

Authors:  Sreeja Sreekumar; Kevin M Levine; Matthew J Sikora; Jian Chen; Nilgun Tasdemir; Dorothy Carter; David J Dabbs; Carolin Meier; Ahmed Basudan; David Boone; Priscilla F McAuliffe; Rachel C Jankowitz; Adrian V Lee; Jennifer M Atkinson; Steffi Oesterreich
Journal:  Endocrinology       Date:  2020-09-01       Impact factor: 4.736

9.  OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation.

Authors:  Jianing Tang; Zeyu Wu; Zelin Tian; Wei Chen; Gaosong Wu
Journal:  Cell Death Dis       Date:  2021-05-25       Impact factor: 8.469

10.  USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α.

Authors:  Jiawei Cao; Du Wu; Guang Wu; Yaqi Wang; Tianhao Ren; Yang Wang; Yingshuai Lv; Wei Sun; Jieyi Wang; Changrui Qian; Licai He; Kaiyan Yang; Hongzhi Li; Haihua Gu
Journal:  Cell Death Dis       Date:  2021-06-15       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.